Regeneron (NASDAQ: REGN) reported Q2 EPS of $11.56, $0.95 better than the analyst estimate of $10.61. Revenue for the quarter came in at $3.55 billion versus the consensus estimate of $3.37 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.